Triple negative breast cancer is cancer that has tested negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 (HER2-).

This type of breast cancer cannot be treated with hormonal therapy or therapies that target the HER2 receptor.

WP Glossary Term Usage